Steris Plc

Strong Financial Performance: STERIS reported a 4% increase in total revenue for Q4 2025, with a remarkable 6% constant currency organic revenue growth driven by volume and a 210 basis point price increase. Adjusted earnings per diluted share rose 40% year-over-year to $2.74, highlighting robust profitability amid ongoing operational efficiencies.

Full-Year Growth and Outlook: For the full fiscal year 2025, STERIS achieved a 6% growth in revenue and a 12% increase in earnings. Looking ahead to fiscal 2026, the company forecasts a revenue growth of 6% to 7%, with each segment expected to contribute similarly. This optimistic outlook includes anticipated price increases of approximately 200 basis points.

Tariff Impact and Cost Mitigation: The company projects a $30 million impact from tariffs in fiscal 2026, with half attributed to China-related tariffs and the other half from the global tariff. Despite this challenge, STERIS expects to mitigate some of these costs through strategic supply chain actions.